About Cecile Magis-Escurra
Role(s) / Profession(s)
Radboud University Nijmegen Medical Centre
Website: http://www.ru.nl/english/faculties/faculty_of_medical/ Type: Academic Institution Country: Netherlands
Cecile Magis-Escurra replied to "intensity of aminoglycoside in the intensive phase of treatment" in the MDR-TB Treatment & Prevention community.
I think the reply of Hossain is a new question... Ronald Karpick makes an interesting remark: "I suspect that the break is good for the TB, allowing greater killing with the intermittent dosing" Why would you suspect greater killing with the intermittenent dose? Is that for the reason Fulvio Salvo ...
Cecile Magis-Escurra started a discussion "intensity of aminoglycoside in the intensive phase of treatment". in the MDR-TB Treatment & Prevention community.
Is anyone using aminoglycosides in MDR three times a week in order to avoid toxicity and to be able to prolong treatment with aminoglycosides for > 6 months? What is known about the pharmacodynamics of this dosing schedule?
- None at this time.